SMAD7 and Cowden disease: Ubiquitination and nuclear translocation of SMAD family member 7 (SMAD7) were mediated by sCYLD to reduce transforming growth factor β signaling in T cells, indicating that sCYLD-SMAD7 complex may be a therapeutic target for CD.